Higher serum concentrations of ACE2 have been associated with obesity, hypertension and lung cancer (considered risk factors for severe disease) [39, 43], and in other studies, a direct correlation of ACE2 with severity and mortality has been found, independent of such comorbidities [44]. Here, ACE2 is linked to obesity due to melanocortin 4 receptor deficiency.